Dr. Maria Margarete Karsten discusses how weekly symptom monitoring helped identify changes between visits and what patients ...

Jim Day was told he had six months to live after a stage 4 melanoma diagnosis. A cancer-fighting virus helped shrink his ...

Patients with cancer who used biosimilar versions of common cancer drugs paid less out of pocket, and their insurers paid ...

Theresa Gannon’s compassion, leadership and dedication to patients and fellow oncology nurses make her an Extraordinary Healer Award nominee.

Theresa Gannon’s compassion, leadership and dedication to patients and fellow oncology nurses make her an Extraordinary ...

Researchers are studying how genetics and environmental factors may influence lung cancer risk and could help shape the ...

Salvage radiation given over 26 sessions kept prostate cancer in check as well as the conventional schedule did, according to ...

Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.

In the phase 2/3 STAR-TREC trial, 78.5% of patients given long-course chemoradiotherapy kept their rectum at 12 months, ...

The U.S. Food and Drug Administration’s approval of Rasonque (daraxonrasib) represents an important advance for patients with ...

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to ...

Nona Baker, 40, was raising three children in West Sussex, England, when a hematologist told her she had an incurable blood ...